Gene expression networks in COPD: microRNA and mRNA regulation

Background The mechanisms underlying chronic obstructive pulmonary disease (COPD) remain unclear. MicroRNAs (miRNAs or miRs) are small non-coding RNA molecules that modulate the levels of specific genes and proteins. Identifying expression patterns of miRNAs in COPD may enhance our understanding of the mechanisms of disease. A study was undertaken to determine if miRNAs are differentially expressed in the lungs of smokers with and without COPD. miRNA and mRNA expression were compared to enrich for biological networks relevant to the pathogenesis of COPD. Methods Lung tissue from smokers with no evidence of obstructive lung disease (n=9) and smokers with COPD (n=26) was examined for miRNA and mRNA expression followed by validation. We then examined both miRNA and mRNA expression to enrich for relevant biological pathways. Results 70 miRNAs and 2667 mRNAs were differentially expressed between lung tissue from subjects with COPD and smokers without COPD. miRNA and mRNA expression profiles enriched for biological pathways that may be relevant to the pathogenesis of COPD including the transforming growth factor β, Wnt and focal adhesion pathways. miR-223 and miR-1274a were the most affected miRNAs in subjects with COPD compared with smokers without obstruction. miR-15b was increased in COPD samples compared with smokers without obstruction and localised to both areas of emphysema and fibrosis. miR-15b was differentially expressed within GOLD classes of COPD. Expression of SMAD7, which was validated as a target for miR-15b, was decreased in bronchial epithelial cells in COPD. Conclusions miRNA and mRNA are differentially expressed in individuals with COPD compared with smokers without obstruction. Investigating these relationships may further our understanding of the mechanisms of disease.

[1]  Gregory P Cosgrove,et al.  Emphysema lung tissue gene expression profiling. , 2004, American journal of respiratory cell and molecular biology.

[2]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[3]  Peter T Nelson,et al.  The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. , 2010, Journal of molecular biology.

[4]  D. Postma,et al.  Altered expression of the Smad signalling pathway: implications for COPD pathogenesis , 2006, European Respiratory Journal.

[5]  P. Paré,et al.  Associations of IL6 polymorphisms with lung function decline and COPD , 2009, Thorax.

[6]  M. Lindsay,et al.  Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids , 2007, BMC Genomics.

[7]  Howard J. Edenberg,et al.  Effects of filtering by Present call on analysis of microarray experiments , 2006, BMC Bioinformatics.

[8]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[9]  M. Ichinose,et al.  Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. , 2007, Pulmonary Pharmacology & Therapeutics.

[10]  Thomas D. Schmittgen,et al.  Integrating the MicroRNome into the study of lung disease. , 2009, American journal of respiratory and critical care medicine.

[11]  R. Flavell,et al.  Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. , 2000, American journal of respiratory cell and molecular biology.

[12]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[13]  P. Barnes,et al.  The cytokine network in chronic obstructive pulmonary disease. , 2009, American journal of respiratory cell and molecular biology.

[14]  D. Groneberg,et al.  SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke , 2004, Biological chemistry.

[15]  B. Celli,et al.  Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.

[16]  S. De Flora,et al.  Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Jin Dai,et al.  Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. , 2002, American journal of respiratory and critical care medicine.

[18]  S. P. Nana-Sinkam,et al.  Lung microRNA: from development to disease , 2009, Expert review of respiratory medicine.

[19]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[20]  P. Paré,et al.  Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. , 2008, American journal of respiratory and critical care medicine.

[21]  J. Vandesompele,et al.  MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[22]  A. Shyu,et al.  Coordinated Changes in mRNA Turnover, Translation, and RNA Processing Bodies in Bronchial Epithelial Cells following Inflammatory Stimulation , 2008, Molecular and Cellular Biology.

[23]  Stefano Volinia,et al.  A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets , 2009, Nature Protocols.

[24]  George A Calin,et al.  Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  B. Berkhout,et al.  A miRNA-tRNA mix-up: tRNA origin of proposed miRNA. , 2010, RNA biology.

[26]  Avrum Spira,et al.  MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium , 2009, Proceedings of the National Academy of Sciences.

[27]  N. Anthonisen,et al.  Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD , 2008, European Respiratory Journal.

[28]  A. Churg,et al.  Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs , 2007, Thorax.

[29]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Schermuly,et al.  Activation of the WNT/β-catenin pathway attenuates experimental emphysema. , 2011, American journal of respiratory and critical care medicine.

[31]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[32]  Naftali Kaminski,et al.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Oliver Eickelberg,et al.  WNT signaling in lung disease: a failure or a regeneration signal? , 2010, American journal of respiratory cell and molecular biology.

[34]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[35]  H. Magnussen,et al.  Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts. , 2010, American journal of respiratory and critical care medicine.

[36]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[37]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.